GAITHERSBURG, Maryland (Reuters) - Pfizer Inc.'s pain reliever Celebrex should be approved for treating rheumatoid arthritis in children despite uncertainty about the risks of long-term use, U.S.

Back in 2004, a popular arthritis drug called Vioxx was pulled off the market when studies showed daily long-term use could increase the risk of heart attack, stroke and death. “This was one of the ...

GAITHERSBURG, Md. — Pfizer Inc. should get American approval to market its Celebrex arthritis-pain pill for use in children because the benefits outweigh the risks, a Food and Drug Administration ...

The Food and Drug Administration on Friday issued a warning on the popular arthritis drug Celebrex after studies showed that high doses of the drug increases the chance of heart attacks and strokes.

NEW YORK (Reuters) - Ads for Pfizer Inc.'s Celebrex arthritis drug are set to splash across U.S. television screens on Monday after more than a two-year hiatus, with an unusual upfront focus on its ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost management strategies.

NEW ORLEANS — A new study gives some reassurance to arthritis sufferers who want pain relief but are worried about side effects. It finds that Celebrex, a drug similar to ones withdrawn 12 years ago ...

A new use for a common painkiller. A medication prescribed to treat pain appears to have the power to keep cancer at bay. Celebrex is an anti-inflammatory used to alleviate symptoms of arthritis, ...

An FDA panel found Celebrex does not cause a greater risk of heart attacks and strokes compared to two other commonly prescribed painkillers, NPR reports. Here are five things to know. 1. Celecoxib is ...

It’s been a painful 15 months both for people with arthritis and for the companies that make their painkilling drugs. The once high-flying anti-inflammatories known as cox-2 inhibitors nearly crashed ...